Literature DB >> 12634359

Distinct mechanisms of neutralization by monoclonal antibodies specific for sites in the N-terminal or C-terminal domain of murine leukemia virus SU.

Michael Dominic Burkhart1, Samuel C Kayman, Yuxian He, Abraham Pinter.   

Abstract

The epitope specificities and functional activities of monoclonal antibodies (MAbs) specific for the murine leukemia virus (MuLV) SU envelope protein subunit were determined. Neutralizing antibodies were directed towards two distinct sites in MuLV SU: one overlapping the major receptor-binding pocket in the N-terminal domain and the other involving a region that includes the most C-terminal disulfide-bonded loop. Two other groups of MAbs, reactive with distinct sites in the N-terminal domain or in the proline-rich region (PRR), did not neutralize MuLV infectivity. Only the neutralizing MAbs specific for the receptor-binding pocket were able to block binding of purified SU and MuLV virions to cells expressing the ecotropic MuLV receptor, mCAT-1. Whereas the neutralizing MAbs specific for the C-terminal domain did not interfere with the SU-mCAT-1 interaction, they efficiently inhibited cell-to-cell fusion mediated by MuLV Env, indicating that they interfered with a postattachment event necessary for fusion. The C-terminal domain MAbs displayed the highest neutralization titers and binding activities. However, the nonneutralizing PRR-specific MAbs bound to intact virions with affinities similar to those of the neutralizing receptor-binding pocket-specific MAbs, indicating that epitope exposure, while necessary, is not sufficient for viral neutralization by MAbs. These results identify two separate neutralization domains in MuLV SU and suggest a role for the C-terminal domain in a postattachment step necessary for viral fusion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12634359      PMCID: PMC150638          DOI: 10.1128/jvi.77.7.3993-4003.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  Identification of a receptor-binding pocket on the envelope protein of friend murine leukemia virus.

Authors:  R A Davey; Y Zuo; J M Cunningham
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Activation of a cell entry pathway common to type C mammalian retroviruses by soluble envelope fragments.

Authors:  D Lavillette; A Ruggieri; S J Russell; F L Cosset
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  O-linked glycosylation of retroviral envelope gene products.

Authors:  A Pinter; W J Honnen
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

4.  Large-scale purification of gp70 from Moloney murine leukemia virus.

Authors:  S W Pyle; D J Chabot; T L Miller; S A Serabyn; J W Bess; L O Arthur
Journal:  J Virol Methods       Date:  1991-05       Impact factor: 2.014

5.  Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1.

Authors:  A Pinter; W J Honnen; S A Tilley; C Bona; H Zaghouani; M K Gorny; S Zolla-Pazner
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

6.  Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: friend-specific and FMR-specific antigens.

Authors:  B Chesebro; K Wehrly; M Cloyd; W Britt; J Portis; J Collins; J Nishio
Journal:  Virology       Date:  1981-07-15       Impact factor: 3.616

7.  Polyclonal bovine sera but not virus-neutralizing monoclonal antibodies block bovine leukemia virus (BLV) gp51 binding to recombinant BLV receptor BLVRcp1.

Authors:  O Orlik; J Ban; J Hlavaty; C Altaner; R Kettmann; D Portetelle; G A Splitter
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

8.  Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice.

Authors:  M J Mendez; L L Green; J R Corvalan; X C Jia; C E Maynard-Currie; X D Yang; M L Gallo; D M Louie; D V Lee; K L Erickson; J Luna; C M Roy; H Abderrahim; F Kirschenbaum; M Noguchi; D H Smith; A Fukushima; J F Hales; S Klapholz; M H Finer; C G Davis; K M Zsebo; A Jakobovits
Journal:  Nat Genet       Date:  1997-02       Impact factor: 38.330

9.  The hypervariable domain of the murine leukemia virus surface protein tolerates large insertions and deletions, enabling development of a retroviral particle display system.

Authors:  S C Kayman; H Park; M Saxon; A Pinter
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  Efficient isolation of novel human monoclonal antibodies with neutralizing activity against HIV-1 from transgenic mice expressing human Ig loci.

Authors:  Yuxian He; William J Honnen; Chavdar P Krachmarov; Michael Burkhart; Samuel C Kayman; Jose Corvalan; Abraham Pinter
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

View more
  13 in total

1.  Role of the mutation Q252R in activating membrane fusion in the murine leukemia virus surface envelope protein.

Authors:  Chi-Wei Lu; Monica J Roth
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

2.  The fusion-controlling disulfide bond isomerase in retrovirus Env is triggered by protein destabilization.

Authors:  Michael Wallin; Maria Ekström; Henrik Garoff
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

3.  Conformational inactivation induces immunogenicity of the receptor-binding pocket of a bacterial adhesin.

Authors:  Dagmara I Kisiela; Victoria B Rodriguez; Veronika Tchesnokova; Hovhannes Avagyan; Pavel Aprikian; Yan Liu; Xue-Ru Wu; Wendy E Thomas; Evgeni V Sokurenko
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

4.  Antibody-induced conformational changes in herpes simplex virus glycoprotein gD reveal new targets for virus neutralization.

Authors:  Eric Lazear; J Charles Whitbeck; Manuel Ponce-de-Leon; Tina M Cairns; Sharon H Willis; Yi Zuo; Claude Krummenacher; Gary H Cohen; Roselyn J Eisenberg
Journal:  J Virol       Date:  2011-11-30       Impact factor: 5.103

5.  Furin cleavage of the Moloney murine leukemia virus Env precursor reorganizes the spike structure.

Authors:  Mathilda Sjöberg; Shang-Rung Wu; Robin Löving; Kimmo Rantalainen; Birgitta Lindqvist; Henrik Garoff
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-07       Impact factor: 11.205

6.  Involvement of the C-terminal disulfide-bonded loop of murine leukemia virus SU protein in a postbinding step critical for viral entry.

Authors:  Michael D Burkhart; Paul D'Agostino; Samuel C Kayman; Abraham Pinter
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

7.  Monoclonal antibody 667 recognizes the variable region A motif of the ecotropic retrovirus CasBrE envelope glycoprotein and inhibits Env binding to the viral receptor.

Authors:  Hanna Dreja; Laurent Gros; Sylvie Villard; Estanislao Bachrach; Anna Oates; Claude Granier; Thierry Chardes; Jean-Claude Mani; Marc Piechaczyk; Mireia Pelegrin
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Effect of epitope position on neutralization by anti-human immunodeficiency virus monoclonal antibody 2F5.

Authors:  Wu Ou; Ning Lu; Sloane S Yu; Jonathan Silver
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

9.  G541R within the 4070A TM protein regulates fusion in murine leukemia viruses.

Authors:  Lucille O'Reilly; Monica J Roth
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

10.  Antibody responses against xenotropic murine leukemia virus-related virus envelope in a murine model.

Authors:  Natalia Makarova; Chunxia Zhao; Yuanyuan Zhang; Sushma Bhosle; Suganthi Suppiah; Jeanne M Rhea; Natalia Kozyr; Rebecca S Arnold; Hinh Ly; Ross J Molinaro; Tristram G Parslow; Eric Hunter; Dennis Liotta; John Petros; Jerry L Blackwell
Journal:  PLoS One       Date:  2011-04-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.